Starpharma (ASX SPL) has been granted marketing approval for the VivaGel® condom in Europe.
It is the only condom of its type incorporating the proprietary compound, astodrimer sodium (SPL7013, VivaGel®) in the condom lubricant.
The European approval applies to all 28 member states of the European Union, including the United Kingdom, a total population of approximately 525 million people.
Starpharma’s marketing partner in Europe, LifeStyles (formerly Ansell) will now undertake marketing preparations ahead of the launch under the brand name Absolute™ DUAL PROTECTION.
The VivaGel® condom is also approved for sale in Japan, Canada and Australia.
Shares in Starpharma (ASX SPL) closed 1.54 per cent higher at $1.32